Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Can three-dimensional pelvimetry using low-dose stereoradiography replace low-dose CT pelvimetry?

Aubry S, Padoin P, Petegnief Y, Vidal C, Riethmuller D, Delabrousse E.

Diagn Interv Imaging. 2018 Sep;99(9):569-576. doi: 10.1016/j.diii.2018.02.008. Epub 2018 Mar 19.

2.

Compared vulnerabilities to small cardiac motions between different cameras used for myocardial perfusion imaging.

Salvadori J, Petegnief Y, Sabbah R, Morel O, Boulahdour H, Karcher G, Marie PY, Imbert L.

J Nucl Cardiol. 2019 Aug;26(4):1313-1322. doi: 10.1007/s12350-017-1175-6. Epub 2018 Jan 11.

PMID:
29327252
3.

Comparative dose levels between CT-scanner and slot-scanning device (EOS system) in pregnant women pelvimetry.

Ben Abdennebi A, Aubry S, Ounalli L, Fayache MS, Delabrousse E, Petegnief Y.

Phys Med. 2017 Jan;33:77-86. doi: 10.1016/j.ejmp.2016.12.008. Epub 2016 Dec 18.

PMID:
27993442
4.

Mapping of failures after radiochemotherapy in patients with non-metastatic esophageal cancer: A posteriori analysis of the dose distribution in the sites of loco-regional relapse.

Bednarek C, Crehange G, Quivrin M, Cueff A, Vulquin N, Chevalier C, Cerda T, Petegnief Y, Mazoyer F, Maingon P, Bosset JF, Servagi Vernat S.

Radiother Oncol. 2015 Aug;116(2):252-6. doi: 10.1016/j.radonc.2015.07.019. Epub 2015 Jul 27.

PMID:
26228970
5.

Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma: SUV-based assessment versus visual analysis.

Lin C, Itti E, Haioun C, Petegnief Y, Luciani A, Dupuis J, Paone G, Talbot JN, Rahmouni A, Meignan M.

J Nucl Med. 2007 Oct;48(10):1626-32. Epub 2007 Sep 14.

6.

Full modelling of the MOSAIC animal PET system based on the GATE Monte Carlo simulation code.

Merheb C, Petegnief Y, Talbot JN.

Phys Med Biol. 2007 Feb 7;52(3):563-76. Epub 2007 Jan 5.

PMID:
17228105
7.

[F-18]-Fluoro-2-deoxy-D: -glucose positron emission tomography as a tool for early detection of immunotherapy response in a murine B cell lymphoma model.

Chaise C, Itti E, Petegnief Y, Wirquin E, Copie-Bergman C, Farcet JP, Delfau-Larue MH, Meignan M, Talbot JN, Molinier-Frenkel V.

Cancer Immunol Immunother. 2007 Aug;56(8):1163-71. Epub 2006 Dec 14.

8.

[Basics of PET and PET/CT imaging: instrumentation and radiopharmaceuticals for clinical diagnosis].

Talbot JN, Petegnief Y, de Beco V, Nataf V, Balard M.

Presse Med. 2006 Sep;35(9 Pt 2):1331-7. Review. French.

PMID:
16969329
9.

Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma.

Moureau-Zabotto L, Touboul E, Lerouge D, Deniaud-Alexandre E, Grahek D, Foulquier JN, Petegnief Y, Grès B, El Balaa H, Kerrou K, Montravers F, Keraudy K, Tiret E, Gendre JP, Grange JD, Houry S, Talbot JN.

Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):340-5.

PMID:
16168829
10.

Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.

Deniaud-Alexandre E, Touboul E, Lerouge D, Grahek D, Foulquier JN, Petegnief Y, Grès B, El Balaa H, Keraudy K, Kerrou K, Montravers F, Milleron B, Lebeau B, Talbot JN.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1432-41. Epub 2005 Aug 25.

PMID:
16125870
11.

[Impact of computed tomography (CT) and 18F-deoxyglucose-coincidence detection emission tomography (FDG-CDET) image fusion for optimisation of conformal radiotherapy in non-small-cell lung cancers].

Deniaud-Alexandre E, Touboul E, Lerouge D, Grahek D, Foulquier JN, Petegnief Y, Grès B, El Balaa H, Keraudy K, Kerrou K, Montravers F, Milleron B, Lebeau B, Talbot JN.

Cancer Radiother. 2005 Sep;9(5):304-15. Epub 2005 Aug 8. French.

PMID:
16087377
12.

In vivo follow-up of rat tumor models with 2-deoxy-2-[F-18]fluoro-D-glucose/dual-head coincidence gamma camera imaging.

Monteil J, Dutour A, Akla B, Chianéa T, Le Brun V, Grossin L, Paraf F, Petegnief Y, Vandroux JC, Rigaud M, Sturtz FG.

Mol Imaging Biol. 2005 May-Jun;7(3):220-8.

PMID:
15912426
14.

Detection of recurrent colorectal carcinoma by 18F-FDG: comparison of the clinical performances of FDG PET and FDG CDET.

Montravers F, Grahek D, Kerrou K, Younsi N, Petegnief Y, de Beco V, Colombet-Lamau C, Talbot JN.

Nucl Med Commun. 2004 Feb;25(2):105-13.

PMID:
15154697
15.

Activity and diffusion of tigecycline (GAR-936) in experimental enterococcal endocarditis.

Lefort A, Lafaurie M, Massias L, Petegnief Y, Saleh-Mghir A, Muller-Serieys C, Le Guludec D, Fantin B.

Antimicrob Agents Chemother. 2003 Jan;47(1):216-22.

16.

[Value of [18F]-fluorodeoxyglucose (FDG) positron emission tomography in digestive cancerology].

Montravers F, Kerrou K, Grahek D, Zerbib E, Mabille L, Younsi N, Petegnief Y, De Beco V, Colombet-Lamau C, Talbot JN.

Presse Med. 2002 Oct 12;31(33):1560-8. Review. French.

PMID:
12422485
17.

[(18F)-fluoro-2-deoxyglucose PET in imaging of gynecologic cancers].

Talbot JN, Grahek D, Kerrou K, Younsi N, de Beco V, Colombet-Lamau C, Petegnief Y, Cailleux N, Montravers F.

Gynecol Obstet Fertil. 2001 Nov;29(11):775-98. Review. French.

PMID:
11770272
18.

[Physical and methodological aspects of multimodality imaging and principles of treatment planning in 3D conformal radiotherapy].

Lefkopoulos D, Foulquier JN, Petegnief Y, Touboul E.

Cancer Radiother. 2001 Oct;5(5):496-514. Review. French.

PMID:
11715302
19.

Advanced radionuclide detection techniques for in vitro and in vivo animal imaging.

Petegnief Y, Aubineau-Laniece I, Kerrou K, Jourdain JR, Talbot JN.

Cell Mol Biol (Noisy-le-grand). 2001 May;47(3):443-51. Review.

PMID:
11441951
20.

Tissular distributions and kinetics of two renal 99mTc-radiopharmaceuticals in rat.

Bonnin F, Petiet A, Petegnief Y, Colas-Linhart N, Bok B.

Cell Mol Biol (Noisy-le-grand). 2001 May;47(3):437-42.

PMID:
11441950
21.
22.

Activity and diffusion of LY333328 in experimental endocarditis due to vancomycin-resistant Enterococcus faecalis.

Saleh-Mghir A, Lefort A, Petegnief Y, Dautrey S, Vallois JM, Le Guludec D, Carbon C, Fantin B.

Antimicrob Agents Chemother. 1999 Jan;43(1):115-20.

23.

Quantitative autoradiography using a radioimager based on a multiwire proportional chamber.

Petegnief Y, Petiet A, Peker MC, Bonnin F, Meulemans A, Le Guludec D.

Phys Med Biol. 1998 Dec;43(12):3629-38.

PMID:
9869037
24.

False-positive somatostatin receptor scintigraphy due to an accessory spleen.

Lebtahi R, Cadiot G, Marmuse JP, Vissuzaine C, Petegnief Y, Courillon-Mallet A, Cattan D, Mignon M, Le Guludec D.

J Nucl Med. 1997 Dec;38(12):1979-81.

25.

Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors.

Lebtahi R, Cadiot G, Sarda L, Daou D, Faraggi M, Petegnief Y, Mignon M, le Guludec D.

J Nucl Med. 1997 Jun;38(6):853-8.

26.

Determination of left ventricular cardiac volume by simultaneous radionuclide angiography and measurement of oxygen consumption at rest and during maximal exercise: a comparison of two non-invasive isotopic procedures.

Faraggi M, Cohen-Solal A, Czitrom D, Sarda L, Lebtahi R, Daou D, Petegnief Y, Gourgon R, Guludec DL.

Nucl Med Commun. 1996 Dec;17(12):1039-46.

PMID:
9004300
27.

Maximum-likelihood estimation: a mathematical model for quantitation in nuclear medicine.

Aubry F, Petegnief Y, Benali H.

J Nucl Med. 1991 May;32(5):898-9. No abstract available.

Supplemental Content

Loading ...
Support Center